Emerging FMS-like tyrosine kinase 3 inhibitors for the treatment of acute myelogenous leukemia

Hillary Prescott, Hagop Kantarjian, Jorge Cortes, Farhad Ravandi

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Emerging FMS-like tyrosine kinase 3 inhibitors for the treatment of acute myelogenous leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences